| Table 2. Comparison of the effects of Vitex and placebo consumption on biochemical characteristics of women with PCOS. | |||||
| Variables | Vitex (n=30) | Placebo (n=30) | p-value |
Effect size (Cohen’s d) | p-value |
|---|---|---|---|---|---|
| TAC (mM) Before After |
0.60±0.02 1.10±0.04 |
0.65±0.02 0.64±0.03 |
0.09 0.001 |
-2.5 13.01 |
0.001 |
| p-value |
0.001 | 0.55 | |||
| TOS (µM) Before After |
11.76±0.55 9.13±0.52 |
13.65±0.94 14.18±0.97 |
0.09 0.001 |
-2.45 -6.48 |
0.001 |
| p-value |
0.001 | 0.58 | |||
| OSI % Before After |
2.00±0.10 0.84±0.04 |
2.12±0.14 2.44±0.24 |
0.51 0.001 |
-0.98 -9.3 |
0.001 |
| p-value |
0.001 | 0.15 | |||
| MDA (µM) | 4.64±0.81 2.99±0.22 |
4.12±0.57 5.63±0.67 |
0.60 0.001 |
0.74 -5.29 |
0.001 |
| Before | |||||
| After | |||||
| p-value |
0.054 | 0.14 | |||
| CAT (KU) Before After |
5.24±0.51 6.98±0.37 |
6.63±0.53 6.86±0.41 |
0.06 0.83 |
-2.67 0.30 |
0.939 |
| p-value |
0.01 | 0.74 | |||
| GPx (mU/ml) Before After |
242.87±2.61 250.75±1.11 |
243.87±2.41 246.65±1.33 |
0.79 0.02 |
-0.39 3.34 |
0.02 |
| p-value |
0.008 | 0.33 | |||
| GSH (µM) | 4.42±0.56 23.94±2.63 |
5.54±0.71 15.20±1.79 |
0.22 0.008 |
-1.75 3.88 |
0.01 |
| Before | |||||
| After | |||||
| p-value |
0.001 | 0.001 | |||
| TT (mM) Before After |
0.139±0.008 0.178±0.014 |
0.146±0.006 0.142±0.006 |
0.50 0.023 |
-0.99 3.34 |
0.01 |
| p-value |
0.018 | 0.48 | |||
| FBS (mg/dl) Before After |
100.23±2.15 84.90±1.15 |
105.13±1.57 90.97±1.23 |
0.071 0.001 |
-2.60 -5.09 |
0.03 |
| p-value |
0.001 | 0.001 | |||
| HOMA-IR Before After |
6.40±1.29 0.983±0.06 |
6.72±0.72 1.33±0.09 |
0.83 0.004 |
-4.53 -0.30 |
0.004 |
| p-value |
0.001 | 0.001 | |||
| TG (mg/dl) Before After |
189.3±14.30 177.83±15.29 |
198.60±14.07 190.60±13.53 |
0.64 0.53 |
-0.88 -0.12 |
|
| 0.57 | |||||
| p-value |
0.001 | 0.09 | |||
| Chol (mg/dl) Before After |
198.66±7.10 174.36±6.89 |
199.43±4.51 187.96±4.70 |
0.93 0.11 |
-0.12 -2.30 |
0.016 |
| p-value |
0.001 | 0.002 | |||
| HDL (mg/dl) Before After |
50.00±1.64 60.13±1.76 |
47.16±1.07 50.93±1.43 |
0.15 0.001 |
2.05 5.73 |
0.001 |
| p-value |
0.001 | 0.002 | |||
| LDL (mg/dl) Before After |
100.43±4.85 81.03±4.68 |
96.20±4.04 93.37±3.96 |
0.51 0.049 |
0.94 -2.84 |
0.001 |
| p-value |
0.001 | 0.001 | |||
| AST (U/l) Before After |
20.46±1.73 17.60±1.41 |
21.43±1.66 20.16±1.48 |
0.68 0.21 |
-0.57 -1.77 |
0.012 |
| p-value‡ | 0.001 | 0.052 | |||
| ALT (U/l) Before After |
22.73±1.77 18.70±1.39 |
22.20±1.64 24.00±1.62 |
0.83 0.016 |
0.31 -3.51 |
0.001 |
| p-value |
0.001 | 0.001 | |||
Note: Results are presented as Mean±SEM. A significance level of 0.05 was considered (p-value<0.05).
† Independent t-test
‡ Paired t-test
§ Based on ANCOVA
Abbreviations: TAC: total antioxidant capacity; TOS: total oxidant status; OSI: oxidative stress index; MDA: malondialdehyde; CAT: catalase; GPx: glutathione peroxidase; GSH: reduced glutathione; TT: total thiol; FBS: fasting blood sugar ; HOMA-IR: homeostatic model assessment-insulin resistance; TG: triglyceride; Chol: cholesterol; HDL: high density lipoprotein; LDL: low density lipoprotein; AST: aspartate aminotransferase; ALT: alanine aminotransferase.